Nicholas Investment Partners’s Relmada Therapeutics RLMD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-243,385	Closed	-$9.01M	–	192
2022 Q3	$9.01M	Buy	+243,385	New	+$9.01M	0.84%	46